Qisda Corporation:企業の戦略・SWOT・財務分析

◆英語タイトル:Qisda Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3355
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Qisda Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Qisda Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Qisda Corporation (Qisda) is a Taiwan-based original equipment manufacturer, original design manufacturer and a hardware-software integrator of electronic products for commercial, consumer, industrial, medical and lifestyle applications. Qisda’s product lines include LCD Monitor; Projector; Medical Service. The company offers products such as All-in-One PC, digital signage & professional displays, projectors, scanners, Industrial automation products such as POS , Mobil POS, AGV , Barcode Reader , Label Printer, multifunctional printers, 3G/4G smartphones, medical gateways, medical imaging and telecare, automobile infotainment devices, e-Reader and tablet. The company has research and development centers in Taiwan and China and manufacturing facilities at Mexico and Taiwan. Qisda sells its products in the America, Asia and Europe. Qisda is headquartered in Guishan, Taoyuan, Taiwan.

Scope

- Detailed information on Qisda Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Qisda Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Qisda Corporation including a breakdown and examination of key business segments
- Intelligence on Qisda Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Qisda Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Qisda Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Qisda Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Qisda Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Qisda Corporation: Company Overview
Qisda Corporation: Overview and Key Facts
Qisda Corporation: Overview
Qisda Corporation: Key Facts
Qisda Corporation: Key Employees
Qisda Corporation: Key Employee Biographies
Qisda Corporation: Major Products and Services
Qisda Corporation: Company History
Qisda Corporation: Management Statement
Qisda Corporation: Locations and Subsidiaries
Qisda Corporation: Key Competitors
Qisda Corporation: Company Analysis
Qisda Corporation: Business Description
Qisda Corporation: SWOT Analysis
Qisda Corporation: SWOT Overview
Qisda Corporation: Strengths
Qisda Corporation: Weaknesses
Qisda Corporation: Opportunities
Qisda Corporation: Threats
Qisda Corporation: Corporate Financial Deals Activity
Qisda Corporation: Financial Deals Overview
Qisda Corporation: Targets and Partners
Qisda Corporation: Top Deals 2015 – 2019YTD*
Qisda Corporation: Advisors
Qisda Corporation: Top Legal Advisors
Qisda Corporation: Mergers and Acquisitions
Qisda Corporation: Corporate Venturing
Qisda Corporation: Recent Developments
Qisda Corporation: News and Events Summary
Qisda Corporation: Financial Deals
Qisda Corporation: Financial Performance
Qisda Corporation: Regulatory and Legal Events
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Qisda Corporation: Key Facts
Table 2: Qisda Corporation: Key Employees
Table 3: Qisda Corporation: Company History
Table 4: Qisda Corporation: Locations and Subsidiaries
Table 5: Qisda Corporation: Key Competitors
Table 6: Qisda Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Qisda Corporation: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Qisda Corporation: Targets and Partners
Table 9: Qisda Corporation: Top Deals 2015 - 2019YTD*
Table 10: Qisda Corporation: Legal Advisor Ranking by Value (US$m)
Table 11: Qisda Corporation: M&A Volume and Value Trend (2015 - YTD*2019)
Table 12: Qisda Corporation: M&A Activity by Geography (2015 - YTD*2019)
Table 13: Qisda Corporation: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 14: Qisda Corporation: Corporate Venturing by Geography (2015 - YTD*2019)
Table 15: Qisda Corporation: News and Events Summary
Table 16: Qisda Corporation: Financial Deals
Table 17: Qisda Corporation: Financial Performance
Table 18: Qisda Corporation: Regulatory and Legal Events

★海外企業調査レポート[Qisda Corporation:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Dialog Group Bhd (DIALOG):企業の財務・戦略的SWOT分析
    Dialog Group Bhd (DIALOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • bioMerieux Inc:医療機器:M&Aディール及び事業提携情報
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • Henkel AG & Co. KGaA:企業の戦略・SWOT・財務情報
    Henkel AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Henkel AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Biogen Inc (BIIB)-製薬・医療分野:企業M&A・提携分析
    Summary Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Zinbry …
  • TWC Enterprises Limited:企業の戦略・SWOT・財務情報
    TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NovaBay Pharmaceuticals Inc (NBY):企業の財務・戦略的SWOT分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid a …
  • NAPEC Inc (NPC):企業の財務・戦略的SWOT分析
    NAPEC Inc (NPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Valneva SE (VLA):企業の財務・戦略的SWOT分析
    Valneva SE (VLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Encompass Health Corp (EHC):企業の財務・戦略的SWOT分析
    Encompass Health Corp (EHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • AGCO Corporation (AGCO):企業の財務・戦略的SWOT分析
    AGCO Corporation (AGCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Solid Biosciences Inc (SLDB):製薬・医療:M&Aディール及び事業提携情報
    Summary Solid Biosciences Inc (Solid Biosciences) is a life science company focused on developing therapies for duchenne muscular dystrophy (DMD). Its pipeline product candidates include SGT-001, a microdystrophin gene therapy administered through adeno-associated virus (AAV) stabilizes dystrophin g …
  • Drugs for Neglected Diseases initiative:製薬・医療:M&Aディール及び事業提携情報
    Summary Drugs for Neglected Diseases initiative (DNDi) is a non-profit drug research and development (R&D) organization which discovers and develops new drugs for neglected diseases. The organization develops therapeutics for the treatment of various diseases such as human African trypanosomiasis (H …
  • REC Solar Inc:電力:M&Aディール及び事業提携情報
    Summary REC Solar Inc (REC Solar), a subsidiary of Duke Energy Corp, is a provider of commercial solar project design and installation programs. The company’s services comprise project development and financing, design and engineering, construction and procurement, operations and maintenance, and te …
  • Geron Corp (GERN):製薬・医療:M&Aディール及び事業提携情報
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • Black Stone Minerals LP (BSM):企業の財務・戦略的SWOT分析
    Summary Black Stone Minerals LP (Black Stone) is a mining and minerals exploration and development company that explores and produces mineral deposits. The company's services include participating on a working interest basis when economics are favorable, leasing minerals to exploration and productio …
  • Rush Enterprises, Inc.
    Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Northern Ireland Electricity Networks Ltd:企業の戦略的SWOT分析
    Northern Ireland Electricity Networks Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • DBK Pharmaceutical:製薬・医療:M&Aディール及び事業提携情報
    Summary DBK Pharmaceutical (DBK Pharma) is a pharmaceutical company that develops, manufactures and markets pharmaceutical, herbal brands, food supplements, cosmetics and veterinary products. The company’s pharmaceutical products include chitocal capsule, debeskon, rentensar tablets, pressothioval, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆